Production and in vivo use of recombinant ovine IL-1β as an immunological adjuvant
- 31 January 1994
- Vol. 12 (1), 14-22
- https://doi.org/10.1016/0264-410x(94)90005-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Enhancement of the protective effect of inactivated influenza virus vaccine by cytokinesVaccine, 1992
- Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IVVaccine, 1992
- Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigsVaccine, 1992
- Cytokines as immunological adjuvantsVaccine, 1992
- Synthetic peptides as vaccinesCurrent Opinion in Immunology, 1992
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- Interleukin 1: the first interleukinImmunology Today, 1990
- Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infectionVeterinary Immunology and Immunopathology, 1989
- Adjuvants for anti-parasite vaccinesParasitology Today, 1989
- The cell surface receptors for interleukin-1α and interleukin-1β are identicalNature, 1986